12
Participants
Start Date
June 10, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
DNP007
DNP007 is a therapeutic agent that can replace calcineurin inhibitor (CNI), which is a representative factor that can be used as an adhesive for extrahepatic long-term survival patches such as after liver transplantation in patients with liver disease and hepatocellular carcinoma, adult metabolic status, neoplasms, etc. , an anti-ICAM-1 mouse monoclonal minority, is a humanized Fab region that humanizes MD-3 and the Fc region of human IgG1, separated by translational engineering.
RECRUITING
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER